Nj State Employees Deferred Compensation Plan Haemonetics Corp Transaction History

Nj State Employees Deferred Compensation Plan

$824 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 18, 2019	SELL	$117.16 - $138.52 $351,480 - $415,560	-3,000 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$81.74 - $120.34 $245,219 - $361,020	-3,000 Reduced 50.0%	3,000 $361,000
Q1 2019 May 01, 2019	BUY	$83.25 - $102.12 $499,500 - $612,720	6,000 New	6,000 $525,000

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$450 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$390 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$335 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$317 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$304 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Account